Airing weekdays at 7:30 A.M. on

Airing weekdays at 7:30 A.M. on

Media Contact
(844) 200-2525


iRULU® and Toys for Tots provide tech for tots with a mission to make a digital difference in a child’s life


(POMPANO BEACH, Fla. – PR LOG – December 2, 2015) With a goal to enrich the lives of as many children as possible with the joys of technology, iRULU Technologies, Inc., known for making smart device technology affordable for everyone, is proud to be a corporate sponsor of Toys for Tots. Both share a joint mission to make a difference in the lives of children who are in need.

There’s a big misconception that only affluent families can afford access to technology. iRULU’s goal is to change that. By keeping 100% of their sales online, they eliminate the high costs of distribution and then pass the savings along to consumers. Their tablets, Smartphones, PCs and other gadgets are high quality with all the features consumers need; and they’re more reasonably priced.

iRULU Technologies, Inc. is taking their mission to make great technology affordable for everyone a step further this holiday season. In the spirit of giving, iRULU is donating one tablet for every 10 purchased on – up to a guaranteed $100,000 worth of tablets — to teens and youth who otherwise wouldn’t have access. The Marine Corps Toys for Tots program will then distribute the thousands of tablets just in time for the holidays.

“We recognize how critical technology is to a young person’s ability to learn, develop and grow – and we’re especially honored to be able to join the Marine Corps’ Toys for Tots in our effort to provide the necessary tools,” said Elizabeth Little, Chief Marketing Officer, iRULU Technologies, Inc. “Through the gift of technology, and a tablet at their fingertips, every child can stay connected in today’s digital world”.

 “iRULU has so much gratitude for our millions of valued customers who’ve supported our brand over the years; it’s because of them that this generous gift is possible,” Little continued.

iRULU is more than a one-stop shop for all one’s technology needs; they are a proud supporter of our nation’s heroes, and their sponsorship of Toys for Toys is just one example of iRULU’s continuous efforts to give back.

For more information on how to help please visit:, and to learn more about iRULU Technologies, Inc. go to:


About iRULU® Technologies, Inc.

iRULU is the consumer electronics division of USA111 Inc, located Groveport, Ohio. iRULU designs and manufacturers Smartphones, tablets and other popular smart devices with cutting-edge features and functionality that rival the big brands — without the big brand price tag. iRULU’s mission is to provide high-quality products at a low price without sacrificing quality, speed, reliability or functionality. To learn more, please visit

About Toys for Tots

Since 1947, Toys for Tots, a non-profit organization run by the United States Marine Corps Reserve has been collecting new, unwrapped toys for children of all ages and distributing them in their local communities during the holiday season to less fortunate children in the community in which the campaign is conducted. The primary goal of Toys for Tots is to deliver, through a new toy at Christmas, a message of hope to less fortunate youngsters that will assist them in becoming responsible, productive, patriotic citizens.

Health, Wealth, Beauty, and Business

Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]

iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.

There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.